Emergent BioSolutions | EBS - Modal Saham Biasa





Modal Saham Biasa Perubahan Tanggal
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
ALKERMES USD 167.54M 1.08M 2026-06
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amarin USD 20.81M 13K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Coherus Biosciences USD 121.16M 4.92M 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Exelixis USD 253.7M 8.78M 2026-03
Glaxosmithkline GBP 4.05B 20.6M 2026-03
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Lonza CHF 68.64M 0 2025-12
Merck USD 2.47B 12.72M 2025-12
Moderna USD 391M 2M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neurocrine Biosciences USD 100.55M 50K 2026-06
Pacira USD 39.31M 1.81M 2026-03
Pfizer USD 5.7B 13M 2026-03
PTC Therapeutics USD 82.88M 1.41M 2026-03
Sanofi EUR 1.21B 8.25M 2026-03
Sarepta Therapeutics USD 105.57M 607K 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
Vanda Pharmaceuticals USD 58K 0 2024-12